Rchr
J-GLOBAL ID：201401076421483609   Update date: Apr. 20, 2024

Horimatsu Takahiro

ホリマツ タカヒロ | Horimatsu Takahiro
Affiliation and department：
Kyoto University

About Kyoto University


Research field  (1)： Tumor diagnostics and therapeutics
Research theme for competitive and other funds  (3)：
  • 2018 - 2022 Evaluation of pharmacokinetics of cancer drugs in patients with renal dysfunction and establishment of administration methods
  • 2018 - 2021 Study for the standardization of the fatigue treatment in end-of-life stage cancer patients
  • 2012 - 2015 Development of new endoscopic system using the composition imaging
Papers (150)：
  • Nobukazu Agatsuma, Takahiro Utsumi, Yoshitaka Nishikawa, Takahiro Horimatsu, Takeshi Seta, Yukitaka Yamashita, Yukari Tanaka, Takahiro Inoue, Yuki Nakanishi, Takahiro Shimizu, et al. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?. World journal of gastroenterology. 2024. 30. 10. 1368-1376
  • Takashi Masuda, Taro Funakoshi, Takahiro Horimatsu, Shinya Yamamoto, Takeshi Matsubara, Sho Masui, Shunsaku Nakagawa, Yasuaki Ikemi, Motoko Yanagita, Manabu Muto, et al. Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series. Cancer chemotherapy and pharmacology. 2024
  • Shigeki Kataoka, Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Minoru Sakuragi, Eiichiro Uchino, Shusuke Hiragi, Shinya Yamamoto, Kaoru Sakai, Takeshi Matsubara, et al. Proteinuria frequency and subsequent renal dysfunction in bevacizumab-treated patients: a single center, retrospective, observational study. International journal of clinical oncology. 2024
  • Yoshitaka Nishikawa, Takahiro Horimatsu, Shiro Oka, Takeshi Yamada, Keigo Mitsui, Hironori Yamamoto, Keiichi Takahashi, Akio Shiomi, Kinichi Hotta, Yoji Takeuchi, et al. Outcomes of Metastatic and Unresectable Small Bowel Adenocarcinoma in Japan According to the Treatment Strategy: A Nationwide Observational Study. JCO global oncology. 2024. 10. e2300392
  • Yoshitaka Nishikawa, Nobukazu Agatsuma, Takahiro Utsumi, Taro Funakoshi, Yukiko Mori, Yuki Nakamura, Nobuaki Hoshino, Takahiro Horimatsu, Takumi Saito, Soichiro Kashihara, et al. Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan. Breast cancer (Tokyo, Japan). 2024. 31. 1. 105-115
ｍore...
MISC (288)：
  • 中村路夫, 船越太郎, 片岡滋貴, 堀松高博, 西川佳孝, 水上拓郎, 後藤知之, 土橋賢司, 馬場英司, 津村剛彦, et al. 血管新生阻害薬使用症例における蛋白尿の発現状況を検討する多施設共同調査研究(VERSiON UP試験). 日本がんサポーティブケア学会学術集会プログラム・抄録集. 2021. 6th (CD-ROM)
  • 中村路夫, 船越太郎, 片岡滋貴, 堀松高博, 西川佳孝, 水上拓郎, 後藤知之, 土橋賢司, 馬場英司, 津村剛彦, et al. 血管新生阻害薬使用症例における蛋白尿の発現状況を検討する多施設共同調査研究(VERSiON UP試験). 日本消化器病学会北海道支部例会・日本消化器内視鏡学会北海道支部例会プログラム・抄録集. 2021. 128th-122nd
  • 山本佳宣, 堀松高博, 矢野友規, 多田春江, 玉置将司, 石原立, 片岡洋望, 森田智視, 小野裕之, 武藤学. 化学放射線療法後の局所遺残再発食道癌に対するタラポルフィンナトリウムと半導体レーザーを用いた光線力学的療法の長期成績. 日本レーザー医学会誌. 2021. 42. 3
  • 山本伸也, 松原雄, 平木秀輔, 坂井薫, 船越太郎, 堀松高博, 武藤学, 柳田素子. 免疫チェックポイント阻害薬開始後の蛋白尿出現頻度と病態解析. 日本腎臓学会誌(Web). 2021. 63. 4
  • 西崎 大輔, 肥田 侯矢, 福井 雄大, 住井 敦彦, 多代 尚広, 渡邉 武志, 稲本 将, 吉冨 摩美, 河田 健二, 西川 佳孝, et al. 「個別化」の視点から内視鏡的切除後のT1直腸癌に対する追加切除の条件を再検する. 日本大腸肛門病学会雑誌. 2019. 72. 5. 291-291
ｍore...
Patents (1)：
  • 生体検査装置および生体検査方法
Association Membership(s) (11)：
Japan Society of Clinical Trials and Research ,  The Japanese Society of Hereditary Tumors ,  The Japan Photodynamic Association ,  The Japanese Society of Colon Examination ,  The Japanese Society of Gastroenterological Cancer Screening ,  The Japanese Gastroenterology Association ,  Japanese Society of Medical Oncology ,  Japan Society of Clinical Oncology ,  Japan Gastroenterological Endoscopy Society ,  The Japanese Society of Gastroenterology ,  The Japanese Society of Internal Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM